Home LiteratureArticle Details
PMID: 7208540 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article

A clinical study on the prolonged antihypertensive effect of clonidine in a sustained-release capsule formulation.

Pharmatherapeutica ·Vol. 2 ·No. 7 ·1980-00-00 ·Pages 456-61

Martens V, Bentsen P, Hochrein H

Abstract

Eight patients with essential hypertension each received a single oral dose of 1 capsule of a sustained-release formulation of 0.25 mg clonidine in the morning for 3 consecutive days. Pulse ratio and blood pressure were measured in the standing and supine positions at specific intervals. After the first day of treatment, a significant decrease in blood pressure lasting 24 hours was recorded for the standing position. In the supine position, there was a progressive decrease in blood pressure which also attained significance on the third day of treatment. There was a progressive and significant reduction in mean arterial pressure from the first to the third day.

MeSH Terms
Adult Aged Blood Pressure/drug effects Capsules Clonidine/administration & dosage,pharmacology Delayed-Action Preparations Evaluation Studies as Topic Female Humans Hypertension/drug therapy Male Middle Aged Posture
Chemicals
Capsules Delayed-Action Preparations Clonidine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Martens V
Bentsen P
Hochrein H
Article Info
Journal
Pharmatherapeutica
Abbr.
Pharmatherapeutica
ISSN
0308-051X
Published
1980-00-00
Pages
456-61
Language
English
Region
England
NLM ID
7606274
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com